CNA is poised to gain from solid retention, favorable renewal premium change and new business growth across Specialty, Commercial and International segments.

TPC's surging Civil segment, backed by a record backlog and higher margins, is fueling optimism for its next growth phase.

CRM trades near 52-week low after a 26.6% YTD drop, but its dominance in the customer relationship management software market and AI focus make it worth holding.

IMTX is advancing Anzu-cel, a T-cell receptor therapy for melanoma with potential for significant annual revenue. Anzu-cel offers advantages over IOVA's Amtagvi, including less invasive cell collection, faster turnaround, and no need for high-dose IL-2. Phase 1b data show a 56% objective response rate and 91% disease control rate in melanoma patients treated with IMTX's therapy.

NEW YORK--(BUSINESS WIRE)---- $JEF #BFA--BFA Law is investigating Jefferies Financial Group Inc., and its fund Point Bonita Capital, for violations of the federal securities laws.

Back-to-Back Developments Position Company for Significant Revenue Acceleration and Recurring Revenue Stream PLEASANTON, CA / ACCESS Newswire / October 10, 2025 / Healthcare Triangle, Inc. (Nasdaq:HCTI), a leader in digital transformation solutions for the healthcare and life sciences industries, has announced two significant developments within the past few days that highlight the company's growing momentum in the AI-powered healthcare technology sector. In an impressive one-week period, Healthcare Triangle has both signed a Letter of Intent to acquire Spain-based Teyame.AI in a transaction expected to generate approximately $34 million in incremental annual revenue, and announced that its wholly-owned subsidiary QuantumNexis has …

JPMorgan stock is outperforming the S&P 500 this year, as Wall Street gets ready for an avalanche of earnings reports in the financial sector.

Discussion aired live on Bloomberg Markets: The Close on October 6, 2025. CHICAGO, IL / ACCESS Newswire / October 10, 2025 / Monroe Capital LLC ("Monroe") Chairman and CEO Ted Koenig appeared on Bloomberg Markets: The Close on October 6, 2025, sharing views on inflation risk, interest-rate cuts, AI infrastructure, and the path for mergers and acquisitions in late 2025.

Granite Construction continues to deliver strong revenue, profit, and cash flow growth, driven by both organic gains and strategic acquisitions. GVA's recent purchases of Warren Paving and Papich Construction are expected to significantly boost EBITDA, operating cash flow, and net income. Despite recent share appreciation, GVA remains undervalued compared to peers, offering substantial upside potential based on relative valuation multiples.

GAITHERSBURG, Md., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company, today announced the execution of a non-binding letter of Intent with Molecule.ai.

Applied Digital stock leaped on Friday after the operator of data centers for artificial intelligence reported a big surge in revenue in its latest quarter.

The stock market was mixed, with AMD and Nvidia lifting the S&P 500 and Nasdaq to highs while the Dow Jones fell. Tesla launched cheap EVs.

AIZ acquires OptoFidelity to benefit the Connected Living business of its Global Lifestyle segment.

As the investing landscape evolves at breakneck speed, two online brokerages, Robinhood Markets HOOD and Charles Schwab SCHW, stand at the forefront of a financial transformation, offering retail investors access to stock and ETF trading. Further, both are competing for market share in the digital investing and wealth management space.

Supernus (SUPN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Besides Wall Street's top-and-bottom-line estimates for Citizens Financial Group (CFG), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.

Grupo Cibest (CIB) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Besides Wall Street's top-and-bottom-line estimates for Rexford Industrial (REXR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Banner (BANR), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Bank of America (BAC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.